Clinical profile of ACS patients and their outcome at tertiary centre in north-eastern Uttar Pradesh, India

Authors

  • M. Sarkari Department of Medicine, B.R.D Medical College, Gorakhpur, Uttar Pradesh, India
  • Ajeet P. Singh Department of Medicine, B.R.D Medical College, Gorakhpur, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20181408

Keywords:

ACS, CAD, TROP I

Abstract

Background: Coronary artery disease (CAD) is a major cause of death in India. This study determined the characteristics, treatment and outcomes of acute coronary syndrome (ACS) at tertiary centre in north eastern Uttar Pradesh in India.

Methods: We carried out observational study with 60-days follow-up of 80 ACS patients. Data are collected on different variables including Blood pressure, pulserate, BNP, TROP I, CKMB, patient’s demography, risk factors, laboratory values at admission and repeated as and when required.  

Results: T In our study most common presentation was chest pain, majority of patients presented after 12 hour of onset of symptoms, elevation of TROP I was higher in STEMI than NSTEMI, most common complication in NSTEMI was recurrent angina and in STEMI patients was heart failure, total 15 patients expired during study 11 during hospitalization and 4 patients within 60days of follow up, thrombolysed patients has less chances of  regional wall motion abnormality.

Conclusions: In our study elevation of TROP I was more in STEMI and there was less chances of RWMA in thrombolysed patients. 

References

Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S. Epidemiological and causation of coronary heart disease and stroke in India. Heart. 2008;94(1):16-26.

Murray CJL, lopez AD. Mortality by cause for eight regions of the world: Global Burden of disease study. Lancet 1997;349(9061):1269-76.

Reddy KS. Cardiovascular diseases in India. World Health Stat Q. 1993;46(2):101-7.

Aguilar D, Fisher MR, O'connor CM, Dunne MW, Muhlestein JB, Yao L, et al. Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. Am Heart J. 2006;152(2):298-304.

Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105(15):1760-3.

Rebuzzi AG, Quaranta G, Liuzzo G, Caligiuri G, Lanza GA, Gallimore JR, et al. Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol. 1998;82(6): 715-9.

Mohanan PP, Mathew R, Harikrishnan S, Krishnan MN, Zachariah G, Joseph J, et al.: Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J 2013,34(2):121-9.

Urban P, Bernstein MS, Costanza M, Simon R, Frey R, Erne P for the AMIS Investigators. An internet-based registry of acute myocardial infarction in Switzerland. Kardiovasc Med. 2000;3:430-0.

Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin- the Euro Heart Survey of Acute Coronary Syndromes. Eur Heart J. 2002;23:1190-201.

Rao SV, Newby LK, Ohman EM, Granger CB, Hasselblad V, Gibler BB et al. Elevated cardiac markers across a spectrum of patients with ACS: defining the role of isolated troponin or CK-MB elevation. Circulation. 2001;104(17):708-9.

Downloads

Published

2018-05-22

Issue

Section

Original Research Articles